Gramicidin S based Mitochondrial Targeting Agents

Organization:University of Pittsburgh, Pa, US
I.P. Brief:Available for license is a mitochondrial targeting agent with potentential treatment capabilities in many disease areas such as mitochondrial disease, hemorrhagic shock, and cancer.
Keywords:Cancer, Mitochondria, Critical Care, targeting
Primary Industry:Pharma & Biotech
Specific Market:Platform technology for targeting Mitochondria

Full IP Descriptions available on-site.

HIGHLIGHTS

Corporate Presentations:

  • Air Products
  • BASF
  • Eastman Kodak Company
  • Genzyme
  • Goodrich
  • Hewlett-Packard
  • Honda
  • Medtronic
  • Merck
  • Sanyo

Reserved Presentations:

  • ExxonMobil
  • IBM

Partnering Events:
(full access included)

Platinum Sponsor
University of Hawaii

Press Sponsor
Business Wire

Commercialization Partner
BusinessWeek

Sponsors
Invest Australia AzTE Technology Enterprises

Media Sponsors
(joint with Nanotech 2007) Nature
Science
Red Herring

Supporting Organizations
BirchBob
CONNECT
Boston University
Midwest Research University Network
OCTANe
AeA
LES-SVC

 

“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
 
Matthew Laudon, Co-Founder and Director of TechConnect